Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
High-Throughput Screening Assays | 11 | 2014 | 940 | 2.220 |
Why?
|
Fluorescence Polarization | 8 | 2019 | 139 | 2.190 |
Why?
|
beta-Lactamases | 10 | 2021 | 307 | 1.790 |
Why?
|
Pseudomonas aeruginosa | 10 | 2021 | 1277 | 1.580 |
Why?
|
Penicillin-Binding Proteins | 9 | 2021 | 152 | 1.390 |
Why?
|
Azabicyclo Compounds | 6 | 2023 | 66 | 1.360 |
Why?
|
Acinetobacter baumannii | 7 | 2023 | 123 | 1.350 |
Why?
|
Topoisomerase II Inhibitors | 7 | 2015 | 94 | 1.300 |
Why?
|
Enzyme Inhibitors | 16 | 2020 | 3726 | 1.250 |
Why?
|
Escherichia coli Proteins | 5 | 2019 | 1055 | 1.210 |
Why?
|
Escherichia coli | 15 | 2021 | 4209 | 1.190 |
Why?
|
Sulbactam | 6 | 2023 | 32 | 1.170 |
Why?
|
Haemophilus influenzae | 7 | 2016 | 177 | 1.170 |
Why?
|
Anti-Bacterial Agents | 28 | 2023 | 7469 | 0.980 |
Why?
|
DNA Ligases | 3 | 2014 | 81 | 0.910 |
Why?
|
DNA, Superhelical | 2 | 2013 | 51 | 0.860 |
Why?
|
DNA Topoisomerases, Type II | 3 | 2015 | 121 | 0.850 |
Why?
|
Boron Compounds | 3 | 2014 | 195 | 0.830 |
Why?
|
Enterobacter cloacae | 2 | 2020 | 25 | 0.760 |
Why?
|
Kinetics | 11 | 2019 | 6287 | 0.730 |
Why?
|
Fluorescence Resonance Energy Transfer | 3 | 2012 | 415 | 0.700 |
Why?
|
Spectrometry, Fluorescence | 2 | 2012 | 694 | 0.660 |
Why?
|
Peptidyl Transferases | 1 | 2019 | 55 | 0.640 |
Why?
|
Ampicillin | 1 | 2019 | 137 | 0.630 |
Why?
|
Drug Discovery | 6 | 2021 | 1068 | 0.620 |
Why?
|
Adenosine Triphosphate | 3 | 2014 | 2001 | 0.620 |
Why?
|
Rhodamines | 1 | 2019 | 179 | 0.620 |
Why?
|
Serine | 1 | 2020 | 828 | 0.550 |
Why?
|
Drug Evaluation, Preclinical | 5 | 2020 | 1331 | 0.540 |
Why?
|
Viral Structural Proteins | 1 | 2014 | 93 | 0.470 |
Why?
|
Sulfones | 1 | 2017 | 447 | 0.470 |
Why?
|
Acetyltransferases | 3 | 2012 | 230 | 0.470 |
Why?
|
Nucleoproteins | 1 | 2014 | 110 | 0.470 |
Why?
|
Gram-Negative Bacteria | 5 | 2021 | 276 | 0.450 |
Why?
|
Adenosine Diphosphate | 2 | 2011 | 421 | 0.430 |
Why?
|
Amino Acyl-tRNA Synthetases | 1 | 2014 | 88 | 0.430 |
Why?
|
Penicillins | 2 | 2014 | 404 | 0.430 |
Why?
|
Drug Design | 6 | 2021 | 1045 | 0.420 |
Why?
|
Leucine-tRNA Ligase | 1 | 2012 | 4 | 0.420 |
Why?
|
NAD | 2 | 2014 | 618 | 0.410 |
Why?
|
Inhibitory Concentration 50 | 6 | 2015 | 464 | 0.400 |
Why?
|
Anisotropy | 1 | 2016 | 1289 | 0.400 |
Why?
|
Microbial Sensitivity Tests | 13 | 2023 | 1969 | 0.400 |
Why?
|
Transferases (Other Substituted Phosphate Groups) | 1 | 2012 | 35 | 0.400 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2014 | 150 | 0.400 |
Why?
|
Carbohydrate Dehydrogenases | 1 | 2011 | 12 | 0.390 |
Why?
|
Multienzyme Complexes | 2 | 2012 | 663 | 0.380 |
Why?
|
Acyltransferases | 1 | 2012 | 305 | 0.360 |
Why?
|
Drug Resistance, Multiple, Bacterial | 4 | 2021 | 592 | 0.360 |
Why?
|
Aminopeptidases | 1 | 2011 | 114 | 0.350 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2014 | 366 | 0.340 |
Why?
|
Ligases | 1 | 2011 | 330 | 0.330 |
Why?
|
S-Adenosylmethionine | 1 | 2011 | 219 | 0.330 |
Why?
|
Liposomes | 1 | 2013 | 787 | 0.330 |
Why?
|
beta-Lactams | 4 | 2020 | 158 | 0.330 |
Why?
|
Methionine | 1 | 2011 | 570 | 0.310 |
Why?
|
Sulfonamides | 4 | 2014 | 1982 | 0.310 |
Why?
|
Binding, Competitive | 4 | 2014 | 1141 | 0.300 |
Why?
|
Antigens, Neoplasm | 2 | 2013 | 1997 | 0.300 |
Why?
|
Adenosine Triphosphatases | 1 | 2012 | 840 | 0.300 |
Why?
|
DNA Gyrase | 4 | 2015 | 86 | 0.270 |
Why?
|
Structure-Activity Relationship | 7 | 2020 | 3052 | 0.260 |
Why?
|
DNA-Binding Proteins | 2 | 2013 | 9612 | 0.260 |
Why?
|
Small Molecule Libraries | 2 | 2012 | 742 | 0.250 |
Why?
|
Molecular Structure | 5 | 2021 | 1882 | 0.240 |
Why?
|
Biocatalysis | 2 | 2013 | 168 | 0.210 |
Why?
|
Morpholines | 3 | 2015 | 584 | 0.210 |
Why?
|
Binding Sites | 7 | 2020 | 6014 | 0.210 |
Why?
|
Naphthyridines | 2 | 2014 | 184 | 0.200 |
Why?
|
Drug Resistance, Bacterial | 5 | 2016 | 1063 | 0.200 |
Why?
|
Rhodanine | 1 | 2021 | 6 | 0.200 |
Why?
|
Nucleoside-Phosphate Kinase | 1 | 2021 | 24 | 0.190 |
Why?
|
Nucleotidyltransferases | 3 | 2012 | 242 | 0.190 |
Why?
|
Bacterial Proteins | 5 | 2016 | 3834 | 0.190 |
Why?
|
Glanders | 1 | 2021 | 1 | 0.190 |
Why?
|
Burkholderia mallei | 1 | 2021 | 4 | 0.190 |
Why?
|
Burkholderia pseudomallei | 1 | 2021 | 7 | 0.190 |
Why?
|
Melioidosis | 1 | 2021 | 9 | 0.190 |
Why?
|
Ceftizoxime | 1 | 2020 | 5 | 0.190 |
Why?
|
Formamides | 1 | 2020 | 22 | 0.180 |
Why?
|
Carrier Proteins | 1 | 2014 | 4925 | 0.180 |
Why?
|
Ceftazidime | 1 | 2020 | 57 | 0.180 |
Why?
|
Burkholderia | 1 | 2021 | 35 | 0.180 |
Why?
|
Monobactams | 2 | 2023 | 16 | 0.180 |
Why?
|
Artifacts | 1 | 2009 | 1904 | 0.180 |
Why?
|
Models, Molecular | 9 | 2021 | 5388 | 0.170 |
Why?
|
Protein Binding | 6 | 2020 | 9327 | 0.170 |
Why?
|
Catalytic Domain | 2 | 2012 | 699 | 0.170 |
Why?
|
Amidohydrolases | 1 | 2020 | 160 | 0.170 |
Why?
|
DNA Topoisomerase IV | 2 | 2015 | 42 | 0.150 |
Why?
|
Fluorescence | 2 | 2011 | 751 | 0.150 |
Why?
|
3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | 1 | 2016 | 10 | 0.140 |
Why?
|
Hydrolysis | 1 | 2017 | 645 | 0.130 |
Why?
|
Species Specificity | 2 | 2017 | 2412 | 0.130 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 2021 | 1137 | 0.130 |
Why?
|
Technetium | 1 | 2015 | 325 | 0.120 |
Why?
|
Spiro Compounds | 1 | 2015 | 69 | 0.120 |
Why?
|
DNA, Bacterial | 2 | 2021 | 1477 | 0.120 |
Why?
|
Barbiturates | 1 | 2015 | 113 | 0.120 |
Why?
|
Siderophores | 1 | 2015 | 61 | 0.120 |
Why?
|
Phenylalanine-tRNA Ligase | 1 | 2014 | 15 | 0.120 |
Why?
|
Anticodon | 1 | 2014 | 24 | 0.120 |
Why?
|
Nicotinamide Mononucleotide | 1 | 2014 | 17 | 0.120 |
Why?
|
Acylation | 1 | 2014 | 98 | 0.120 |
Why?
|
Drug Combinations | 1 | 2020 | 2086 | 0.110 |
Why?
|
Ciprofloxacin | 2 | 2015 | 313 | 0.110 |
Why?
|
Chromatography, Gel | 1 | 2014 | 634 | 0.110 |
Why?
|
Fluorescent Dyes | 2 | 2012 | 1928 | 0.110 |
Why?
|
Least-Squares Analysis | 1 | 2014 | 369 | 0.110 |
Why?
|
Periplasm | 1 | 2013 | 43 | 0.110 |
Why?
|
Uridine Diphosphate N-Acetylglucosamine | 1 | 2012 | 18 | 0.100 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2013 | 205 | 0.100 |
Why?
|
Myristic Acids | 1 | 2012 | 49 | 0.100 |
Why?
|
Ligands | 2 | 2012 | 3273 | 0.100 |
Why?
|
Acyl Carrier Protein | 1 | 2012 | 24 | 0.100 |
Why?
|
Amino Acid Sequence | 3 | 2014 | 13411 | 0.100 |
Why?
|
Rats, Wistar | 2 | 2015 | 1885 | 0.100 |
Why?
|
Dimerization | 1 | 2014 | 882 | 0.100 |
Why?
|
Lipid A | 1 | 2012 | 70 | 0.100 |
Why?
|
Adenosine Monophosphate | 1 | 2014 | 232 | 0.100 |
Why?
|
Recombinant Proteins | 2 | 2012 | 6507 | 0.100 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2013 | 273 | 0.100 |
Why?
|
Amino Acid Motifs | 1 | 2014 | 928 | 0.100 |
Why?
|
Polyribonucleotide Nucleotidyltransferase | 1 | 2011 | 6 | 0.100 |
Why?
|
Cell Wall | 2 | 2012 | 419 | 0.100 |
Why?
|
Proteins | 1 | 2007 | 6001 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1085 | 0.100 |
Why?
|
Phosphorylation | 2 | 2014 | 8310 | 0.100 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2014 | 1729 | 0.100 |
Why?
|
Enzyme Activation | 3 | 2015 | 3587 | 0.100 |
Why?
|
Molecular Sequence Data | 3 | 2014 | 17608 | 0.100 |
Why?
|
Cytidine Diphosphate | 1 | 2011 | 1 | 0.100 |
Why?
|
Nonlinear Dynamics | 1 | 2014 | 490 | 0.100 |
Why?
|
Acetyl Coenzyme A | 1 | 2011 | 74 | 0.090 |
Why?
|
Uridine Diphosphate | 1 | 2011 | 35 | 0.090 |
Why?
|
Guanosine Diphosphate | 1 | 2011 | 79 | 0.090 |
Why?
|
Etoposide | 1 | 2013 | 639 | 0.090 |
Why?
|
Pyruvates | 1 | 2011 | 84 | 0.090 |
Why?
|
Enzyme Assays | 1 | 2012 | 103 | 0.090 |
Why?
|
Cations, Divalent | 1 | 2011 | 167 | 0.090 |
Why?
|
Allosteric Regulation | 1 | 2012 | 424 | 0.090 |
Why?
|
Crystallography, X-Ray | 4 | 2020 | 1947 | 0.090 |
Why?
|
Edetic Acid | 1 | 2011 | 277 | 0.090 |
Why?
|
Protein Structure, Quaternary | 1 | 2011 | 424 | 0.090 |
Why?
|
Pseudomonas Infections | 1 | 2015 | 623 | 0.090 |
Why?
|
Oxazines | 1 | 2012 | 358 | 0.090 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2012 | 366 | 0.090 |
Why?
|
Hemodynamics | 1 | 2020 | 4186 | 0.090 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2014 | 2745 | 0.080 |
Why?
|
Rats | 5 | 2020 | 23713 | 0.080 |
Why?
|
Peptidoglycan | 1 | 2011 | 246 | 0.080 |
Why?
|
Absorption | 1 | 2009 | 243 | 0.080 |
Why?
|
Lysine | 1 | 2014 | 998 | 0.080 |
Why?
|
Half-Life | 2 | 2020 | 648 | 0.080 |
Why?
|
Scintillation Counting | 1 | 2009 | 36 | 0.080 |
Why?
|
Pyruvate Kinase | 1 | 2011 | 191 | 0.080 |
Why?
|
Protein Structure, Tertiary | 2 | 2013 | 3760 | 0.080 |
Why?
|
Doxorubicin | 1 | 2015 | 2229 | 0.080 |
Why?
|
Manganese | 1 | 2011 | 393 | 0.070 |
Why?
|
Staphylococcus aureus | 2 | 2013 | 1429 | 0.070 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 1197 | 0.070 |
Why?
|
Luminescent Measurements | 1 | 2009 | 342 | 0.070 |
Why?
|
Plasmids | 1 | 2013 | 2268 | 0.070 |
Why?
|
Carbapenems | 2 | 2020 | 125 | 0.070 |
Why?
|
Gene Expression | 2 | 2017 | 7587 | 0.070 |
Why?
|
Reference Standards | 1 | 2011 | 1011 | 0.070 |
Why?
|
Acinetobacter Infections | 2 | 2018 | 73 | 0.070 |
Why?
|
Staphylococcal Infections | 2 | 2013 | 1396 | 0.070 |
Why?
|
Calibration | 1 | 2009 | 817 | 0.070 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2007 | 136 | 0.070 |
Why?
|
Protein Multimerization | 1 | 2011 | 961 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 1 | 2014 | 3738 | 0.060 |
Why?
|
Mutation | 6 | 2020 | 30211 | 0.060 |
Why?
|
Specimen Handling | 1 | 2009 | 706 | 0.060 |
Why?
|
Mice | 8 | 2021 | 81912 | 0.060 |
Why?
|
Light | 1 | 2009 | 1358 | 0.050 |
Why?
|
Observer Variation | 1 | 2009 | 2616 | 0.050 |
Why?
|
Fluoroquinolones | 2 | 2015 | 307 | 0.050 |
Why?
|
Aza Compounds | 1 | 2021 | 34 | 0.050 |
Why?
|
Cyclooctanes | 1 | 2021 | 37 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13650 | 0.050 |
Why?
|
DNA | 2 | 2015 | 7210 | 0.050 |
Why?
|
RNA | 1 | 2011 | 2715 | 0.050 |
Why?
|
Acetylglucosamine | 2 | 2012 | 188 | 0.040 |
Why?
|
Peptides | 1 | 2012 | 4348 | 0.040 |
Why?
|
Animals | 9 | 2021 | 168965 | 0.040 |
Why?
|
Drug Industry | 1 | 2007 | 791 | 0.040 |
Why?
|
Microbial Viability | 1 | 2021 | 236 | 0.040 |
Why?
|
Horses | 1 | 2021 | 294 | 0.040 |
Why?
|
Protein Conformation | 2 | 2021 | 3948 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2698 | 0.040 |
Why?
|
Gram-Positive Bacteria | 1 | 2020 | 180 | 0.040 |
Why?
|
Prodrugs | 1 | 2020 | 274 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 426 | 0.040 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2021 | 1168 | 0.030 |
Why?
|
Escherichia coli Infections | 1 | 2020 | 518 | 0.030 |
Why?
|
Genome, Bacterial | 1 | 2021 | 796 | 0.030 |
Why?
|
Humans | 13 | 2020 | 767040 | 0.030 |
Why?
|
Haemophilus Infections | 1 | 2016 | 94 | 0.030 |
Why?
|
Enterobacteriaceae | 1 | 2017 | 161 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2018 | 447 | 0.030 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2017 | 238 | 0.030 |
Why?
|
Oxazolidinones | 1 | 2015 | 98 | 0.030 |
Why?
|
Isoxazoles | 1 | 2015 | 233 | 0.030 |
Why?
|
Research Design | 1 | 2009 | 6210 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2011 | 20169 | 0.030 |
Why?
|
Azepines | 1 | 2015 | 329 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2018 | 1716 | 0.030 |
Why?
|
Uridine Triphosphate | 1 | 2012 | 29 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 6226 | 0.030 |
Why?
|
Neisseria gonorrhoeae | 1 | 2015 | 249 | 0.030 |
Why?
|
Dogs | 1 | 2017 | 3834 | 0.020 |
Why?
|
Administration, Oral | 1 | 2020 | 4026 | 0.020 |
Why?
|
Skin Diseases | 1 | 2020 | 1083 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 40154 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2012 | 487 | 0.020 |
Why?
|
Rifampin | 1 | 2012 | 350 | 0.020 |
Why?
|
Amides | 1 | 2012 | 451 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2020 | 8108 | 0.020 |
Why?
|
Algorithms | 1 | 2009 | 14098 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6310 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2012 | 2176 | 0.020 |
Why?
|
Quinazolines | 1 | 2012 | 1369 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 5750 | 0.020 |
Why?
|
Streptococcus pneumoniae | 1 | 2010 | 764 | 0.020 |
Why?
|
Female | 4 | 2021 | 396660 | 0.010 |
Why?
|
Male | 3 | 2020 | 364203 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18330 | 0.010 |
Why?
|
Bacteria | 1 | 2012 | 2212 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8048 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 17097 | 0.010 |
Why?
|
Neoplasms | 1 | 2015 | 22350 | 0.000 |
Why?
|